Purpose: To ascertain the Knowledge levels, Attitudes and Beliefs towards Organ Donation by Relatives of Patients in the Intensive Care Unit at two Tertiary Care Hospitals in Trinidad. Methods: A quantitative descriptive study in which the researchers’-designed and pretested self-administered questionnaire was used on a sample of 133 randomly selected patients’ relatives from two main intensive care hospitals units of Trinidad. The respondents were requested to give their consent after necessary ethical approval was received. Data entry was done manually but the analysis was done with the SPSS version 12 programme. Results were presented as frequencies. Results: Demographic characteristics indicate that most were females, of African ethnicity, and Christianity as their main religion. The majority of participants had high level of knowledge (69.2%) while 57.9% of them had unfavourable attitude towards organ donation. Most (86.5%) had positive belief. It also showed that the respondents’ knowledge towards organ donation is significantly related to their age and religion, (P≤, 0.05) while their attitudes are significantly related to their gender and ethnicity (p≤0.05). Their belief is only significantly associated with their marital status. Discussion: The findings of the study were compared with previous studies and the researchers showed how the relevant theories that guided the study were used to explain the findings. Conclusion: Based on the findings, the researchers made a number of recommendations particularly related to public education in attempt to address the attitudes of the public related to organ donation in Trinidad and Tobago.
Background. Down-scheduling one or more triptans to Schedule 3 (Pharmacist Only Medicine) from Schedule 4 (Prescription Only Medicine) has been debated in Australia for a decade. This study aimed to evaluate the perspectives and readiness of Western Australian (WA) community pharmacists to manage migraine including over-the-counter (OTC) provision of triptans. Methods. Data were collected using a self-administered paper-based questionnaire, posted to a random sample of 178 metropolitan and 97 regional pharmacies in WA. Respondent pharmacists were surveyed regarding: knowledge of optimal migraine treatment as per current guidelines, resources required to appropriately recommend triptans, and attitudes and perspective toward down-scheduling. Data were analysed using descriptive statistics and multivariate regression analysis. Pharmacist/pharmacy characteristics influencing readiness were evaluated by assigning respondents a score based on responses to Likert scale questions. These questions were assigned to five domains based on an implementation model, and these scores were used in a general linear model (GLM) to identify demographic characteristics associated with readiness across each domain. Results. A total of 114 of the 275 pharmacies returned useable questionnaires (response rate: 41.5%). The two most commonly recommended first line OTC agents were a combined paracetamol/non-steroidal anti-inflammatory drugs and aspirin (44/104; 42.3% and 22/104; 21.2%, respectively) which provided context to the respondents' knowledge of optimal migraine treatment. Responses to questions in relation to triptans and the warning signs requiring referral were in line with current guidelines, demonstrating respondents' knowledge in these areas. Nevertheless, most respondents demonstrated uncertainty in relation to the pathogenesis of migraine. If triptans were available OTC, 66/107 (61.7%) would recommend them first-line. The majority (107/113; 94.7%) agreed that down-scheduling would improve timely access to effective migraine medication, and 105/113 (92.9%) agreed that if triptans were downscheduled, pharmacists may be better able to assist people in the treatment of migraine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.